Gene: CHID1
Official Full Name: chitinase domain containing 1provided by HGNC
Gene Summary: Enables oligosaccharide binding activity. Involved in negative regulation of cytokine production involved in inflammatory response. Located in several cellular components, including late endosome; lysosome; and trans-Golgi network. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18724 | CHID1 Knockout cell line (HeLa) | Human | CHID1 | 1:3~1:6 | Negative | Online Inquiry |
KO18725 | CHID1 Knockout cell line (HCT 116) | Human | CHID1 | 1:2~1:4 | Negative | Online Inquiry |
KO18726 | CHID1 Knockout cell line (HEK293) | Human | CHID1 | 1:3~1:6 | Negative | Online Inquiry |
KO18727 | CHID1 Knockout cell line (A549) | Human | CHID1 | 1:3~1:4 | Negative | Online Inquiry |
CHID1 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study and exploration of the CHID1 gene’s biological functions and its implications in various disease states. These cell lines have been engineered to disrupt the expression of the CHID1 gene, allowing researchers to investigate the resulting phenotypic and molecular changes that occur in its absence.
The key function of CHID1 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for studying gene functionality and interaction pathways. By knocking out the CHID1 gene, researchers can elucidate its role in cellular processes such as metabolism, signaling, and development. This is particularly valuable in elucidating its involvement in diseases, such as cancer and neurodegenerative disorders, wherein the CHID1 gene may play a critical role. The knockout mechanism typically employs CRISPR-Cas9 technology, providing precision and reproducibility in generating the desired mutations.
The scientific importance of these cell lines is underscored by their applications in both fundamental and translational research. In research settings, they serve as vital tools for functional genomics, enabling scientists to dissect gene function at a level that can convey insights into disease mechanisms. Clinically, they can be utilized for drug screening, biomarker discovery, and therapeutic target validation, thus bridging the gap between bench and bedside.
Compared to alternative methods, such as transient knockdown techniques, CHID1 Gene Knockout Cell Lines provide a more stable and long-term solution for studying gene function, making them exceptionally useful for prolonged experiments. This stability allows for consistent experimental conditions, ultimately leading to more reliable and replicable results.
For researchers and clinicians dedicated to advancing our understanding of genetic roles in health and disease, these knockout cell lines offer an invaluable resource that enhances both the depth and breadth of scientific inquiry. Our company, a leader in genetic engineering and cell line development, is committed to supplying high-quality biological products that empower scientific innovation and discovery. With our expertise and dedication to excellence, we are proud to offer CHID1 Gene Knockout Cell Lines as a cornerstone for your research initiatives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.